AI Tool Reads Biopsy Images to Predict Mantle Cell Lymphoma Outcomes

Researchers developed an AI tool called MAIPI that uses routine biopsy images to predict mantle cell lymphoma patient outcomes, matching the prognostic accuracy of specialized Ki-67 staining and TP53 molecular testing. This approach could provide a lower-cost, faster prognostic method in clinical settings lacking access to expensive molecular testing.

This Wire brief sits within Fusion42's coverage of AI Frontier Models, Diagnostics and Medtech.